|Bid||42.17 x 0|
|Ask||42.20 x 0|
|Day's Range||40.55 - 42.71|
|52 Week Range||17.91 - 56.70|
|Beta (5Y Monthly)||0.67|
|PE Ratio (TTM)||1,356.45|
|Earnings Date||Feb. 25, 2021|
|Forward Dividend & Yield||0.66 (1.57%)|
|Ex-Dividend Date||Feb. 25, 2021|
|1y Target Est||57.20|
28, 2021 /CNW Telbec/ - Boralex Inc. ("Boralex" or "the Corporation") announces that the release of the 2020 Fourth quarter results will take place on Thursday, February 25, 2021, at 10 a.
Transformative partnership reunites University of Toronto and Novo Nordisk to commemorate the 100th anniversary of the discovery of insulin and jumpstart a new era in precision public healthTORONTO and BAGSVÆRD, Denmark, Feb. 24, 2021 /CNW/ - Novo Nordisk A/S and the University of Toronto (U of T) today announced a DKK 200 million (CAD 40 million) investment to establish the Novo Nordisk Network for Healthy Populations.
Has declared a quarterly dividend of $0.165 per common share. This dividend will be paid on March 15, ...